Additionally, B cell-derived microvesicles circulating in CLL plasma can deliver constitutively phosphorylated Axl to BMSCs to enhance the tumor microenvironment and recruit additional tyrosine kinases, and not surprisingly, this phosphorylation status correlates with clinical prognosis [82, 83]. This evidence concerns the gene AXL and neoplasm.